Navigating Pharmacogenomic Testing Coverage in Medicare Populations
Enrollment options
This online, self-paced, text-based module educates healthcare professionals towards a better understanding of the benefits and limitations of direct-to-consumer pharmacogenomic testing, when to pursue confirmatory clinical testing, and how to interpret pharmacogenomic test results using evidence-based resources.
It was developed by the National Human Genome Research Institute (NHGRI) Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG).
To access, log in to our site (to right of this page; free registration) and click 'continue' to enroll (it's free!).
Planning Committee for the ISCC-PEG Pharmacogenomics Learning Series: Course Directors
Sara Rogers, PharmD, BCPS
American Society of Pharmacovigilance
Texas A&M University
Benjamin Brown
American Society of Pharmacovigilance
Christine Formea, PharmD, BCPS, FCCP, FASHP
Children’s Hospital Colorado
Additional Content Reviewers
TARGET AUDIENCE
All healthcare professionals
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:- Define relevant reimbursement related terminology
- Review key components of payer coverage guidance for pharmacogenomics testing
- Describe technical requirements for test reports
- Understand special documentation requirements to show medical necessity